Literature DB >> 19042302

Understanding and overcoming barriers to substance abuse treatment access for people with mental retardation.

Elspeth M Slayter1.   

Abstract

People with mental retardation have experienced increasing levels of freedom and access to community living over the past 40 years. This has included access to alcohol, illicit drugs and the potential for developing substance abuse and related problems. The manner in which people with mental retardation have handled this access has been recognized since the de institutionalization era began. Despite this recognition, documented barriers to accessing substance abuse treatment for people with mental retardation exist and there is an overarching lack of knowledge about accessible treatment approaches for this population. Policy and practice recommendations are presented for disability and rehabilitation social workers in order to better understand and combat barriers to substance abuse treatment.

Entities:  

Mesh:

Year:  2008        PMID: 19042302     DOI: 10.1080/15367100802009780

Source DB:  PubMed          Journal:  J Soc Work Disabil Rehabil        ISSN: 1536-710X


  5 in total

1.  Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines.

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

2.  Primary care of adults with developmental disabilities: Canadian consensus guidelines.

Authors:  William F Sullivan; Joseph M Berg; Elspeth Bradley; Tom Cheetham; Richard Denton; John Heng; Brian Hennen; David Joyce; Maureen Kelly; Marika Korossy; Yona Lunsky; Shirley McMillan
Journal:  Can Fam Physician       Date:  2011-05       Impact factor: 3.275

3. 

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

Review 4.  Substance abuse among individuals with intellectual disabilities.

Authors:  Shawna L Carroll Chapman; Li-Tzy Wu
Journal:  Res Dev Disabil       Date:  2012-03-07

5.  Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities.

Authors:  Kosuke Okazaki; Manabu Makinodan; Kazuhiko Yamamuro; Tomoyo Takata; Toshifumi Kishimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-14       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.